Page 111 - Clinical Development News Today

Six Dragonfly-developed drugs are presently in the clinic. WALTHAM, Mass., June 1, 2023 /PRNewswire/ -- Dragonfly Therapeutics, Inc., today announced it has expanded its clinical leadership

Dublin, May 31, 2023 (GLOBE NEWSWIRE) -- The "Chinese Biopharma, Clinical Development, CRO Utilization and Outlook 2023" report has been added to ...

IAMA Therapeutics, a preclinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel medicines to make a difference in the lives of children affected by

A small molecule drug candidate from Algiax Pharmaceuticals can reduce excitability of neurons in relation to chronic pain, dampening signal and reducing pain, a study shows.

Studies show a wearable monitor, described as a ‘game changer’ in the fight against Parkinson’s Disease (PD) has proven it is more than 95% accurate, PD Neurotechnology says.

31.05.2023 - –   TransCon IL-2 β/γ in Phase 1 clinical trial showed monotherapy clinical activity in heavily pre-treated cancer patients with clear dose dependent response on cytotoxic immune cells –   TransCon IL-2 β/γ administered every 3 weeks was ... Seite 1

Pamela Tenaerts, chief scientific officer at Medable, is on a mission to democratize and diversify clinical trials.

/PRNewswire/ -- Indiana Center For Recovery is pleased to announce that it has become a Wellbriety Certified Treatment Center at its Mishawaka location,...

A partnership has been formed between Allucent, a biopharma services provider, has partnered with Thread, a decentralized clinical trial (DCT) and eCOA technology provider to launch Allucent Patient Direct Trials, a DCT focusing on small and mid-sized biotech companies.

A drug that has the ability to ‘transform the landscape’ for people living with metastatic colorectal cancer (CRC) has been granted priority review by the US Food and Drug Administration (FDA).